Results
|
|
1.
|
Benefits and Harms of Continuous Intravenous Inotropic Support as Palliative Therapy: A Single-Institution, Retrospective Analysis. MedStar authors:
- Foley, Carroll
- Gholami, Sherry
- Groninger, Hunter
- Najjar, Samer S
- Rao, Anirudh
- Sheikh, Farooq H
- Singh, Manavotam
Year: 2024
Citation: - American Journal of Hospice & Palliative Medicine. 41(1):50-55, 2024 Jan.
Institution:
- MedStar Heart & Vascular Institute
- MedStar Washington Hospital Center
Department:
- Cardiovascular Disease Fellowship
- Internal Medicine Residency
- Medicine/Palliative Care
- MedStar Georgetown University Hospital/MedStar Washington Hospital Center
- Social Work
Medline publication type:
All authors: - Rao A, Maini M, Anderson KM, Crowell NA, Gholami SS, Foley Lgsw C, Violanti D, Singh M, Sheikh FH, Najjar SS, Groninger H
|
|
|
2.
|
Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure. MedStar authors:
Year: 2020
Citation: - Journal of the American College of Cardiology. 76(6):669-679, 2020 08 11.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Ahmed A, Allman RM, Arundel C, Deedwania P, Faselis C, Filippatos G, Fonarow GC, Gottlieb SS, Lam PH, Morgan CJ, Nguyen T, Patel S, Sheriff HM, Wopperer S, Zeng Q, Zile MR
|
|
|
3.
|
|
|
|
4.
|
Continuous Inotrope Therapy in Hospice Care: A Case Series. MedStar authors:
- Groninger, Hunter
- Patel, Krishna
Year: 2019
Citation: - American Journal of Hospice & Palliative Medicine. 36(7):660-663, 2019 Jul.
Institution: - MedStar Washington Hospital Center
Department:
- Medicine/Palliative Care
- Pharmacy
Medline publication type:
All authors: - D'Souza A, Groninger H, Patel K
|
|
|
5.
|
Digoxin Initiation and Outcomes in Patients with Heart Failure (HFrEF and HFpEF) and Atrial Fibrillation. MedStar authors:
Year: 2020
Citation: - American Journal of Medicine. 133(12):1460-1470, 2020 12.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Ahmed A, Allman RM, Anker MS, Arundel C, Deedwania P, Faselis C, Fonarow GC, Karasik PA, Lam PH, Moore H, Morgan CJ, Singh S, Tummala L, Wopperer S, Zeng Q
|
|
|
6.
|
Digoxin Use and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction. MedStar authors:
- Bayoumi, Essraa
- Lam, Phillip H
Year: 2019
Citation: - American Journal of Medicine. 132(11):1311-1319, 2019 11.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Abdelmawgoud A, Ahmed A, Allman RM, Bayoumi E, Fonarow GC, Kanonidis IE, Lam PH, Malik A, Morgan CJ, Packer M, Qamer SZ, Singh S
|
|
|
7.
|
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial. MedStar authors:
Year: 2021
Citation: - Nature Medicine. 27(10):1818-1824, 2021 10.
Department: - MedStar Heart and Vascular Institute
Medline publication type:
All authors: - Axelsson A, Bach RG, Becker JR, Benson L, Braunwald , Bundgaard H, Burns KM, Canter C, Cirino AL, Colan SD, Day SM, Ho CY, Lakdawala NK, Lever HM, MacRae CA, Margossian R, McMurray JJV, Mestroni L, Murphy AM, Orav EJ, Owens AT, Patel AR, Pereira AC, Rossano JW, Russell MW, Seidman CE, Solomon SD, Soslow JH, Taylor MRG, Thrush P, VANISH Investigators, Vargas JD, Wheeler MT, Wilmot I, Zahka K
|
|
|
8.
|
Renin-Angiotensin Inhibition and Outcomes in Nursing Home Residents With Heart Failure. MedStar authors:
- Lam, Phillip H
- Mohammed, Selma F
Year: 2020
Citation: - American Journal of Therapeutics. 27(3):e235-e242, 2020 May/Jun.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Ahmed A, Allman RM, Arundel C, Faselis C, Fonarow GC, Jones LG, Jurgens CY, Lam PH, Mohammed SF, Morgan CJ, Sheriff HM
|
|
|
9.
|
Reverse Remodeling Effects of Sacubitril-Valsartan: Structural and Functional Optimization in Stage C Heart Failure. MedStar authors:
Year: 2024
Citation: - American Journal of Cardiology. 210:249-255, 2024 Jan 01.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Kalanatari S, Oren D, Medvedofsky D, Narang A, Imamura T, Tayazime S, Kim GH, Raikhelkar J, Sayer G, Lang RM, Uriel N
|
|
|
10.
|
Changes in serum potassium levels during hospitalization in patients with worsening heart failure and reduced ejection fraction (from the EVEREST trial). MedStar authors:
Year: 2015
Citation: - American Journal of Cardiology. 115(6):790-6, 2015 Mar 15.
Institution: - MedStar Heart & Vascular Institute
All authors: - Butler J, Campia U, Chioncel O, EVEREST Trial Investigators, Gheorghiade M, Khan SS, Konstam MA, Maggioni AP, Nodari S, Rossignol P, Senni M, Subacius H, Swedberg K, Vaduganathan M, Zannad F
|
|
|
11.
|
|
|
|
12.
|
Digoxin use and lower risk of 30-day all-cause readmission in older patients with heart failure and reduced ejection fraction receiving beta-blockers. MedStar authors:
- Bhyan, Poonam
- Dooley, Daniel J
- Lam, Phillip H
- Mohammed, Selma F
Year: 2018
Citation: - Clinical Cardiology. 41(3):406-412, 2018 Mar.
Institution:
- MedStar Heart & Vascular Institute
- MedStar Washington Hospital Center
Department: - Medicine/Internal Medicine
Medline publication type:
All authors: - Ahmed A, Allman RM, Aronow WS, Arundel C, Bhyan P, Dooley DJ, Fonarow GC, Lam PH, Mohammed SF, Morgan CJ, Sheriff HM, Waagstein F
|
|
|
13.
|
Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction. MedStar authors:
- Brar, Vijaywant
- Gill, Gauravpal S
- Lam, Phillip H
Year: 2020
Citation: - American Journal of Medicine. 133(10):1187-1194, 2020 10.
Institution:
- MedStar Heart & Vascular Institute
- MedStar Washington Hospital Center
Department: - Medicine/Internal Medicine
Medline publication type:
All authors: - Ahmed A, Allman RM, Arundel C, Brar V, Cheng Y, Fonarow GC, Gill GS, Lam PH, Levy WC, Packer M, Singh SN, Wu WC, Zile MR
|
|
|
14.
|
|
